Update to “Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors”
Article in The Oncologist (April 2022)
The most recent citing publication is shown below. View this citation on Dimensions.